FIX KUPON EXPRESS ZERTIFIKAT - PFIZER INC | Delayed Deutsche Boerse AG 11:20:53 2024-05-21 am EDT | ||
| 86.2 EUR | -0.28% |
|
| Current month | +7.58% | ||
| 1 month | +7.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 86.2 | -0.28% |
| 24-05-20 | 86.44 | -0.02% |
| 24-05-17 | 86.46 | -0.30% |
| 24-05-16 | 86.72 | -0.31% |
| 24-05-15 | 86.99 | +0.68% |
Delayed Quote Deutsche Boerse AG
Last update May 21, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| WKN | PD99CU |
| ISIN | DE000PD99CU3 |
| Date issued | 2023-06-30 |
| Strike | 38.3 $ |
| Maturity | 2027-06-23 (1128 Days) |
| Parity | 0.04 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | both |
| Currency | EUR |
Technical Indicators
| Highest since issue | 98.19 € |
|---|---|
| Lowest since issue | 77.61 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.53
USD
Average target price
31.94
USD
Spread / Average Target
+11.95%
- Stock Market
- Certificates
- Certificat
